Ativo Capital Management’s Fortis FTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-21,588
Closed -$1.02M – 81
2022
Q2
$1.02M Sell
21,588
-3,915
-15% -$192K 0.69% 84
2022
Q1
$1.26M Buy
25,503
+77
+0.3% +$3.61K 0.65% 86
2021
Q4
$1.23M Sell
25,426
-501
-2% -$22.7K 0.54% 93
2021
Q3
$1.15M Buy
25,927
+2,349
+10% +$106K 0.54% 93
2021
Q2
$1.04M Sell
23,578
-1,686
-7% -$76K 0.44% 103
2021
Q1
$1.1M Buy
25,264
+3
+0% +$123 0.47% 95
2020
Q4
$1.03M Buy
25,261
+1
+0% +$41 0.44% 97
2020
Q3
$1.03M Hold
25,260
– – 0.5% 82
2020
Q2
$962K Hold
25,260
– – 0.52% 84
2020
Q1
$974K Sell
25,260
-302
-1% -$12.4K 0.61% 57
2019
Q4
$1.06M Hold
25,562
– – 0.49% 80
2019
Q3
$1.08M Sell
25,562
-1
-0% -$41 0.53% 76
2019
Q2
$1.01M Buy
25,563
+4
+0% +$151 0.45% 85
2019
Q1
$945K Sell
25,559
-12,390
-33% -$440K 0.4% 95
2018
Q4
$1.27M Buy
37,949
+10
+0% +$337 0.59% 56
2018
Q3
$1.23M Sell
37,939
-37
-0.1% -$1.2K 0.33% 116
2018
Q2
$1.21M Hold
37,976
– – 0.34% 115
2018
Q1
$1.28M Sell
37,976
-940
-2% -$31.9K 0.36% 108
2017
Q4
$1.43M Buy
+38,916
New +$1.44M 0.38% 90

Other funds holding FTS

Ativo Capital Management's FTS Position: Q3 2022 in Review

Ativo Capital Management sold out of Fortis (FTS) in Q3 2022, closing a stake of 21,588 shares — an estimated $1.02M sold.

Ativo Capital Management first reported a position in FTS in Q4 2017 and held it in 19 quarters. The position peaked at $1.43M in Q4 2017. 272 funds tracked by Wall St. Rank hold FTS as of Q3 2022.

  • Ativo Capital Management reported no remaining Fortis position as of Q3 2022 after selling out during the quarter.
  • Ativo Capital Management sold 21,588 Fortis shares in Q3 2022, an estimated $1.02M.
  • Ativo Capital Management first reported a position in Fortis in Q4 2017 and held it in 19 quarters.
  • Ativo Capital Management's Fortis position peaked at $1.43M in Q4 2017.
  • 272 funds tracked by Wall St. Rank held Fortis as of Q3 2022.

Based on Ativo Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.